Yanbo Yuan

ORCID: 0000-0003-4467-6398
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Mental Health Research Topics
  • Neurotransmitter Receptor Influence on Behavior
  • Healthcare Decision-Making and Restraints
  • Cognitive Functions and Memory
  • Tryptophan and brain disorders
  • Functional Brain Connectivity Studies
  • Mental Health and Psychiatry
  • Obsessive-Compulsive Spectrum Disorders
  • Immune Cell Function and Interaction
  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • MicroRNA in disease regulation
  • Attention Deficit Hyperactivity Disorder
  • Treatment of Major Depression
  • Advanced Neuroimaging Techniques and Applications
  • Bipolar Disorder and Treatment
  • GABA and Rice Research
  • Pharmacogenetics and Drug Metabolism
  • Neural dynamics and brain function
  • Hydrogen Storage and Materials
  • Reproductive System and Pregnancy
  • Autism Spectrum Disorder Research
  • Lipid metabolism and biosynthesis
  • Signaling Pathways in Disease

Peking University
2008-2023

Peking University Sixth Hospital
2008-2023

Guangdong Academy of Medical Sciences
2022

Guangdong Provincial People's Hospital
2022

National Clinical Research
2021

Ministry of Health of the Russian Federation
2015

State Key Laboratory of Pharmaceutical Biotechnology
2015

Chinese Academy of Medical Sciences & Peking Union Medical College
2015

Objective: Diagnosis of schizophrenia is currently dependent on symptom-based criteria and lacks objective indicators. In this study, the authors investigated whether circulating miRNA can serve as a diagnostic biomarker for schizophrenia. Methods: Global plasma miRNAs were profiled in test cohort 164 patients 187 control subjects, using Solexa sequencing, TaqMan Low Density Array, quantitative reverse transcription polymerase chain reaction (qRT-PCR) assays. The captured then validated by...

10.1176/appi.ajp.2015.14030273 article EN American Journal of Psychiatry 2015-07-17

Purpose: This study aimed to investigate the efficacy and tolerability of aripiprazole, olanzapine risperidone in first-episode schizophrenia (FES). Methods: The eight-week, open, randomised was conducted six Chinese medical centres. Altogether, 498 FES subjects were aripiprazole ( n = 165), 168) or 165). Efficacy measured with Positive Negative Syndrome Scale (PANSS), Udvalg for Kliniske Undersogelser Side Effect Rating (UKU) functioning Personal Social Performance (PSP). Results: All three...

10.1177/0269881119872193 article EN Journal of Psychopharmacology 2019-09-05

We performed an association study between three SNPs in the genes of 14-3-3 family and paranoid schizophrenia. SNP rs983583 G/A YWHAZ gene showed significant with Our indicated that was a potential susceptibility for schizophrenia population studied.

10.1016/j.eurpsy.2004.07.006 article EN European Psychiatry 2004-08-27

Abstract Frizzled 3 ( FZD3 ) gene is located on chromosome 8p21, a region that has been implicated in schizophrenia genetic linkage studies. The transmembrane receptor required for Wnt signal transduction cascades have thought to be involved producing the cytoarchitectural defects observed schizophrenia. Previous work showed strong association between locus and family‐based study. To confirm this issue further, we investigated four single nucleotide polymorphisms (SNPs) by case‐control study...

10.1002/ajmg.b.30076 article EN American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004-06-28

Abstract Monoamine oxidase A (MAOA) is the enzyme responsible for degradation of several monoamines, such as dopamine and serotonin that are considered being two most important neurotransmitters involved in pathophysiology schizophrenia. To study a possible role MAOA gene conferring susceptibility to schizophrenia, present genotyped variable number tandem repeat (VNTR) polymorphism 41 SNPs across this among 555 unrelated patients with paranoid schizophrenia 567 healthy controls. Quantitative...

10.1002/ajmg.b.32009 article EN American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2011-12-07

Background Sustained attention deficits have been associated with schizophrenia. However, these findings were limited to patients schizophrenia and cannot be generalized a wider nonclinical sample schizotypal personality features. Objectives This study aimed examine the sensitivity of theory-driven test, Attention Response Task (SART), in individuals We also investigated relationships between different parameters SART dimensions Methods One hundred ninety-nine participants (74 schizophrenia,...

10.1097/wnn.0b013e3181b7ef84 article EN Cognitive and Behavioral Neurology 2009-09-01

Dysfunctions of glutamatergic and GABAergic neurotransmission are two important hypotheses for the pathogenesis schizophrenia. Thus, genes in pathway candidates schizophrenia susceptibility. Phosphate-activated glutaminase (GLS), glutamine synthetase (GLUL), glutamic acid decarboxylase (GAD), GABA transaminase (ABAT) succinic semialdehyde dehydrogenase (ALDH5A1) five primary enzymes glutamate synthetic degradative pathway. In order to investigate possible involvement these development...

10.1016/j.eurpsy.2004.09.028 article EN European Psychiatry 2004-12-16

Introduction: Cognitive impairment is a core feature of schizophrenia. The effects atypical antipsychotics on the cognitive functions patients with first-episode schizophrenia have not been comprehensively investigated so far. This study aims to compare neurocognitive risperidone, olanzapine, and aripiprazole for schizophrenia.Methods: was multicenter, randomized, open-label clinical trial. 546 were randomly divided into three medication groups, followed up 1 year. performance evaluated...

10.1080/08039488.2020.1771767 article EN Nordic Journal of Psychiatry 2020-06-04

Several lines of evidence suggest that dysfunctions neurotransmitters are associated with schizophrenia. DOPA decarboxylase (DDC) is an enzyme involved directly in the synthesis dopamine and serotonin, indirectly noradrenaline. Therefore, DDC gene can be considered a candidate for We performed association study between three single nucleotide polymorphisms paranoid However, our no significant differences were found genotype distributions allele frequencies 80 schizophrenics 108 controls any...

10.1097/00041444-200409000-00008 article EN Psychiatric Genetics 2004-08-18

To investigate the persistent remission rate (PRR) and its predictors within first year of antipsychotic treatment in first-episode schizophrenia (FES) patients.In a sample 301 FES patients who remained for 1 year, we assessed symptoms with Positive Negative Syndrome Scale (PANSS), cognition six domains functioning Personal Social Performance (PSP).In total, 75.4% (227/301) remaining reached (PR) one year. The PSP score was higher remitters than non-remitters at endpoint 1-year follow-up (P...

10.3389/fpsyt.2020.00566 article EN cc-by Frontiers in Psychiatry 2020-06-19

Objective: To explore the effect of long-term antipsychotics use on strength functional connectivity (FC) in brains patients with chronic schizophrenia. Method: We collected resting-state magnetic resonance imaging from 15 continuously treated schizophrenia (TCS), 19 minimally TCS (MTCS), and 20 healthy controls (HCs). Then, we evaluated compared whole-brain FC (FCS; including full-range, short-range, long-range FCS) among TCS, MTCS, HCs. Results: Patients MTCS showed reduced...

10.1177/0706743720904815 article EN The Canadian Journal of Psychiatry 2020-02-06

Abstract We genotyped six SNPs in the genes of p450 family among paranoid schizophrenics and normal controls. All subjects are unrelated Han Chinese. Three showed polymorphic, no significant differences allele or genotype frequencies were detected between patients Thus we obtained evidence for involvement polymorphisms schizophrenia population investigated.

10.1016/j.eurpsy.2004.04.017 article EN European Psychiatry 2004-09-01

Environmental stressors may influence immune surveillance in B lymphocytes and stimulate autoimmune responses via epigenetic DNA methylation modifications schizophrenia (SCZ).

10.1093/schizbullopen/sgac047 article EN cc-by Schizophrenia Bulletin Open 2022-11-09

Background Lipid storage myopathy (LSM) is an autosomal recessive inherited lipid and amino metabolic disorder with great clinical heterogeneity. Variations in the electron transfer flavoprotein dehydrogenase (ETFDH) gene cause multiple acyl-CoA deficiency (MADD), have a manifestation of LSM. Muscle biopsy helps clarify diagnosis LSM, next-generation sequencing (NGS) can be useful identifying genomic mutation sites. The MADD contributes to targeted therapy. Case presentation We report on...

10.3389/fneur.2022.991060 article EN cc-by Frontiers in Neurology 2022-12-15

Objective To describe negative symptoms in ultra-high-risk individuals of schizophrenia. Methods Twenty-two patients, 23 acute schizophrenia 18 stable patients from the Sixth Hospital Peking University were enrolled May 1st, 2012 to Mar 30th, 2013. The Positive and Negative Syndrome Scale (PANSS) for Assessment Symptoms (SANS) used assess each group. characteristic symptom among three groups was compared. Results The SANS scores group higher than those (58.68±21.29 vs....

10.3760/cma.j.issn.1006-7884.2015.01.003 article EN Chin J Psychiatry 2015-02-05
Coming Soon ...